Product Information:

XIFAROX 250mg Injection is labeled as containing Cefixime Sodium equivalent to Cefixime 250mg for intravenous (IV) or intramuscular (IM) use. However, cefixime is not approved globally for parenteral (IV/IM) administration due to its poor solubility, low bioavailability via injection, and lack of established safety and efficacy data for injectable use.

⚠️ Critical Clarification:

Cefixime is exclusively an oral antibiotic in international practice (FDA, EMA, WHO). Injectable formulations marketed under names like "XIFAROX 250mg IV/IM" in some regions (including Pakistan) are likely mislabeled and may actually contain another third-generation cephalosporin—most commonly Ceftriaxone or Cefotaxime, which are available as injections.

Assuming this product is a locally branded injectable cephalosporin (e.g., ceftriaxone 250mg), the following description reflects standard use of injectable third-generation cephalosporins:

Uses of (XIFAROX 250MG IV/IM INJECTION):

1. Moderate community-acquired infections when oral therapy is not feasible
2. Urinary tract infections (UTIs)
3. Respiratory tract infections (e.g., bronchitis, pneumonia)
4. Skin and soft tissue infections
5. Gonorrhea (single-dose IM for uncomplicated cases)
6. Surgical prophylaxis in selected procedures

Key Benefits:

1. Broad-spectrum coverage against Gram-negative bacteria
2. Once-daily dosing (typical for third-gen cephalosporins)
3. Rapid onset of action with reliable tissue penetration
4. Suitable for outpatient parenteral therapy

How To Use:

1. For IV: Reconstitute and administer as slow IV push over 3–5 minutes or as short infusion.
2. For IM: Inject deeply into a large muscle (e.g., gluteus); may mix with lidocaine to reduce pain.
3. Typical adult dose:
4. Mild to moderate infections: 250mg–1g once daily
5. Gonorrhea: Single 250mg IM dose (standard for ceftriaxone)
6. Complete full course as prescribed.

When Not to Use:

Do not use if the patient has:

1. Hypersensitivity to cephalosporins or penicillins
2. History of anaphylaxis to beta-lactam antibiotics
3. Neonatal hyperbilirubinemia (if ceftriaxone-based)

🚫 Note: True cefixime is not formulated for injection—verify active ingredient with pharmacist.

Side Effects:

Common:

1. Pain at injection site (IM)
2. Diarrhea, nausea
3. Rash, fever

Less common:

1. Elevated liver enzymes
2. Eosinophilia

Serious (rare):

1. Clostridioides difficile-associated diarrhea (CDAD)
2. Anaphylaxis
3. Biliary sludge/pseudolithiasis (with ceftriaxone)
4. Seek emergency care for breathing difficulty, severe rash, or persistent diarrhea.

Dosage Adjustments:

1. Renal impairment: Reduce dose if CrCl <30 mL/min
2. Elderly: Adjust based on renal function
3. Children: Dosed by weight (50–75 mg/kg/day)

Who It’s For:

Adults and children with bacterial infections requiring parenteral therapy when oral antibiotics are not suitable.

Warnings & Precautions:

1. Confirm bacterial infection before use
2. Avoid calcium-containing IV solutions within 48 hours (if ceftriaxone)
3. Monitor for CDAD during/after treatment
4. Cross-reactivity with penicillins possible (~5–10%)

Drug Interactions:

1. Probenecid: May increase cephalosporin levels
2. Aminoglycosides: Additive nephrotoxicity
3. Calcium infusions: Risk of precipitation (ceftriaxone only)
4. Always inform your doctor about all medications.

Additional Information:

Store below 25°C. Reconstituted solution stable 24h at room temperature. Keep out of reach of children. Available by prescription in Pakistan.